The ASSIST CLAD study: A phase 2 randomized controlled trial of mesenchymal stromal cells for new-onset chronic lung allograft dysfunction

已完结 10 由 poppy 发布于 2026/8/21 12:10:47

DOI:10.1016/j.healun.2026.03.032
作者：Daniel C. Chambers MBBS, MD, Glen Westall MBBS, PhD, David Darley MBBS, PhD, Michael Musk MBBS, Allan R. Glanville MD, Monique Malouf MD, Chien-Li Holmes-Liew MBBS, MCSc,
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：BackgroundChronic lung allograft dysfunction (CLAD) remains the primary limitation to long-term survival after lung transplantation. We conducted a multicenter, phase 2, double-blind, random

应助信息

9小时前

打酱油

7c21e2e39d1711f1abb534735aa3bc31.pdf 已采纳

9小时前

Book学术机器人

2026/8/21 12:10:47 未找到该文献，机器人已退出，请等待人工下载

2026/8/21 12:10:47 Book学术AI机器人收到请求，开始寻找文献

2026/8/21 12:10:47 已向机器人发送请求

9小时前

poppy 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Chemical Society (ACS)Viscoelasticity and Sol–Gel Transition via Multiscale Self-Assembled Nanostructures in Short-Side-Chain PFSA Dispersions